As Bob Iger prepares to step down, the Disney CEO used an earnings call to outline a clear vision for his successor: evolution is non-negotiable. With the board nearing a decision, the media giant stands at a pivotal crossroads.
Pfizer reported a quarterly loss driven by significant asset impairments and declining COVID-19 product sales, sending shares lower. The pharmaceutical giant reaffirmed its 2026 financial targets but signaled no share buybacks as it prioritizes debt reduction and a costly R&D pipeline aimed at replacing lost patent revenues.
Armed with artificial intelligence, a new wave of solo entrepreneurs is competing in the consumer packaged goods arena, using the technology for everything from market research to strategic planning—tasks once reserved for large corporate teams.
As global trust in U.S. leadership wavers, a deeper crisis of economic mobility threatens the American Dream. The path forward may lie not in more capitalism, but in cultivating a new breed of capitalists who share prosperity.
Panasonic Energy announced its De Soto facility is scaling up to 50% operational capacity within months, with construction on a major second wing now underway, signaling robust growth amid a shifting EV policy landscape.
Willis Towers Watson reported robust fourth-quarter and full-year 2025 results, driven by its specialization strategy and digital investments. The global advisory, broking, and solutions firm announced key acquisitions, including Newfront, and outlined a confident outlook for mid-single-digit organic growth and margin expansion in the coming year.
A surge in early Social Security filings has many retirees questioning their choice. For those who change their minds, the SSA offers a limited-time escape hatch—but the rules and repercussions are critical to understand.
The Walt Disney Company has appointed longtime executive Josh D'Amaro as its next Chief Executive Officer, succeeding Bob Iger in a planned transition. D'Amaro, who currently leads Disney's theme parks division, will assume the role in March with a compensation package valued at approximately $38 million.
The health insurance giant is rolling out an 'Agent Assist' tool to its 20,000+ call center workers, aiming to boost efficiency, accuracy, and consistency in member service while targeting over $100 million in operational savings.
Professional services firm S&W has named Marcus Peaker, a former PwC executive compensation lead, to head its own practice in the field, aiming to address growing corporate scrutiny on remuneration structures.
The iconic New York bakery appoints former Jamba and Jimmy John's executive Nathan Louer to lead its next growth phase, while longtime leader Bobbie Lloyd transitions to chief brand officer.
Medtronic moves to acquire CathWorks and its AI-powered coronary artery disease diagnostic system, aiming to solidify its position in the catheterization lab and streamline treatment decisions.
Peter Mandelson, the former UK ambassador to the US and a senior Labour figure, has announced his retirement from the House of Lords as pressure mounts over his disclosed ties to the late financier and convicted sex offender Jeffrey Epstein. The move follows Prime Minister Keir Starmer's condemnation and comes as authorities on both sides of the Atlantic review potential misconduct.
Marius Borg Høiby, the son of Crown Princess Mette-Marit, has pleaded not guilty to multiple counts of rape and sexual assault as his trial begins. The case, involving 38 charges from several alleged victims, has cast a shadow over the Norwegian royal household.
A routine call at a Stone Mountain hotel turned deadly Sunday morning, leaving a young Gwinnett County officer dead and his colleague fighting for his life after an alleged credit card fraud suspect opened fire.
Vera Therapeutics elevates Matt Skelton to Chief Commercial Officer, signaling a strategic shift towards commercialization as its lead drug candidate, atacicept for IgA nephropathy, undergoes FDA Priority Review with a PDUFA date set for July 2026.
As clinical-stage biotech Alumis sees its stock price skyrocket on optimism for its autoimmune disease pipeline, one investment fund has made a contrarian move, selling its entire position just before a major rally.
After narrowly avoiding a key psychological threshold, MicroStrategy's stock remains tethered to Bitcoin's price. Conflicting technical signals and a critical support level set the stage for a potential 20% move in either direction.
Prediction markets for specific words spoken by NFL broadcasters are seeing explosive growth ahead of Super Bowl LX, with millions staked on niche wagers despite league objections and advertising bans.
Disney's board has tapped Josh D'Amaro, the longtime executive behind its lucrative parks and experiences division, to succeed Bob Iger as CEO. The move signals a focus on operational excellence and core assets as the company navigates industry upheaval.
